Central Trust Company’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8
Closed -$147 1642
2025
Q4
$147 Buy
+8
New +$148 ﹤0.01% 1518
2022
Q4
Sell
-9
Closed 1316
2022
Q3
$0 Buy
+9
New +$133 ﹤0.01% 1398
2022
Q1
Sell
-6
Closed 1469
2021
Q4
$0 Buy
+6
New +$85 ﹤0.01% 1324
2016
Q1
Sell
-933
Closed -$19K 1157
2015
Q4
$19K Buy
933
+223
+31% +$4.7K ﹤0.01% 870
2015
Q3
$16K Buy
710
+100
+16% +$2.55K ﹤0.01% 889
2015
Q2
$16K Hold
610
﹤0.01% 908
2015
Q1
$20K Hold
610
﹤0.01% 825
2014
Q4
$19K Sell
610
-46
-7% -$1.27K ﹤0.01% 830
2014
Q3
$16K Buy
+656
New +$18.2K ﹤0.01% 900

Other funds holding SBRA

Central Trust Company's SBRA Position: Q1 2026 in Review

Central Trust Company sold out of Sabra Healthcare REIT (SBRA) in Q1 2026, closing a stake of 8 shares — an estimated $147 sold.

Central Trust Company first reported a position in SBRA in Q3 2014 and held it in 9 quarters. The position peaked at $20K in Q1 2015. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • Central Trust Company reported no remaining Sabra Healthcare REIT position as of Q1 2026 after selling out during the quarter.
  • Central Trust Company sold 8 Sabra Healthcare REIT shares in Q1 2026, an estimated $147.
  • Central Trust Company first reported a position in Sabra Healthcare REIT in Q3 2014 and held it in 9 quarters.
  • Central Trust Company's Sabra Healthcare REIT position peaked at $20K in Q1 2015.
  • 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.